MorphoSys presents latest data from the Phase 2 MANIFEST Stu

DGAP-News: MorphoSys AG / Key word(s): Miscellaneous/Conference12.12.2021 / 15:00 The issuer is solely responsible for the content of this announcement.MorphoSys presents latest data from the Phase 2 MANIFEST Study evaluating the potential of pelabresib in the treatment of myelofibrosis Data presented during poster...

Related Keywords

Germany , Georgia , United States , Munich , Bayern , Atlanta , American , Srdan Verstovsek , Development Officer , Janssen Biotech Inc , American Society Of Hematology Annual Meeting , Drug Administration , Morphosys Group , Md Anderson Cancer Center , Constellation Pharmaceuticals Inc , Janssen Research Development , Morphosys Us Inc , Nasdaq , Distribution Services , Exchange Commission , Constellation Pharmaceuticals , American Society , Hematology Annual Meeting , Malte Peters , Morphosys Chief Research , Cancer Center , Janssen Research , Janssen Biotech , Morphosy Annual Report , Corporate News , Regulatory Announcements ,